Celsion Corp
CLSN·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$18.68
Today
+0.9%
YTD
+0.0%
About
Operating within the US, Celsion develops and commercialises directed chemotherapies and RNA-based therapies to treat cancer and DNA-mediated immunotherapy. Based in Lawrenceville, New Jersey, the company was founded in 1982. The company's stock is available under the ticker CLSN on the NASDAQ CM. Diversify your portfolio today by investing in CLSN stock.
Price chart
Closing price history for CLSN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-0.32
P/S (TTM)0.00
P/B (TTM)1.38
Market cap$6.96M
Cap tierMicro-cap
Industry avg P/E-2.18
Profitability
Gross margin100.00%
EBIT margin0.00%
Net margin-10586.14%
ROE-430.25%
ROA-123.77%
Earnings & Revenue
Revenue (TTM)$0.00
Revenue growth (1Y)-100.0%
EPS (TTM)-$3.84
Free cash flow$-15.18M
Total debt$7.85M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.41
Employees20
Next earnings14 Nov '22
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.